This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange fell 10.07 points to 828.48 Wednesday. Alistair MacLennan's halted NEX shell, Four River Ventures Ltd. (FFC), plans to acquire Canabo Medical Corp. The shell will roll back 1 for 2, leaving it with 2,536,450 postconsolidated shares issued, then issue 20,606,700 postconsolidated shares to Canabo's shareholders.

Canabo operates the Cannabinoid Medical Clinic (CMClinic), which offers physical exams to patients, usually those claiming to suffer from chronic pain, and then prescribes cannabinoid (or marijuana) treatments to them as applicable. Patients must first get a note from a doctor (no walk-ins). Once a patient receives a prescription from CMClinic, he can take it to any licensed producer of medical marijuana.

The first CMClinic branch opened in Toronto in July, 2014. There are now seven branches, including three outside Ontario: in Halifax, St. John's and Edmonton. As of May, 2016, Canabo had over 6,000 patients. As well as running CMClinic, the company holds seminars for doctors. Topics include chronic pain management and the proper administration of medical marijuana. Canabo also conducts research on medical marijuana. In the first quarter of 2015, it formed research partnerships with Tweed Marijuana Inc. (now Canopy Growth Corp. (CGC: $3.96)) and private Toronto licensed producer CannTrust Inc.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS